310
Participants
Start Date
August 11, 2025
Primary Completion Date
May 25, 2028
Study Completion Date
May 25, 2028
E coli vaccine 1 Dose A
Candidate E coli vaccine 1 Dose A, administered according to a 0, 6-month interval
E coli vaccine 1 Dose B
Candidate E coli vaccine 1 Dose B, administered according to a 0, 6-month interval
E coli vaccine 2
Candidate E coli vaccine 2, administered according to a 0, 6-month interval
E coli vaccine 3
Candidate E coli vaccine 3, administered according to a 0, 6-month interval
E coli Vaccine 4 Dose A
Candidate E coli vaccine 4 Dose A, administered according to a 0, 6-month interval
E coli Vaccine 4 Dose B
Candidate E coli vaccine 4 Dose B, administered according to a 0, 6-month interval
E coli Vaccine 4 Dose C
Candidate E coli vaccine 4 Dose C, administered according to a 0, 6-month interval
E coli Vaccine 5 Dose A
Candidate E coli vaccine 5 Dose A, administered according to a 0, 6-month interval
E coli Vaccine 5 Dose B
Candidate E coli vaccine 5 Dose B, administered according to a 0, 6-month interval
Placebo
Placebo administered according to a 0, 6-month interval
NOT_YET_RECRUITING
Miami Eye Institute, Hollywood
NOT_YET_RECRUITING
Research Centers of America ( Hollywood ), Hollywood
NOT_YET_RECRUITING
Research Centers of America, Hollywood
NOT_YET_RECRUITING
University Eye Specialists, P.C. (Ophthalmologist), Maryville
NOT_YET_RECRUITING
Alliance for Multispecialty Research, LLC, Knoxville
NOT_YET_RECRUITING
Alliance for Multispecialty Research, LLC, Knoxville
NOT_YET_RECRUITING
Senders Pediatrics, South Euclid
RECRUITING
CTI Clinical Research Center, Cincinnati
NOT_YET_RECRUITING
Anaheim Clinical Trials, LLC, Anaheim
RECRUITING
Diablo Clinical Research, Inc., Walnut Creek
Lead Sponsor
Pfizer
INDUSTRY